The Immuno-oncology-Induced Cytokine Release Syndrome Patient Diary: A Content-Valid, Patient-Reported Outcome Measure
The "IO-induced CRS patient diary" can be considered a content-valid tool for capturing and monitoring the most important patient-reportable symptoms and impacts of CRS in IO clinical trials. This PROM can provide a standardized understanding of IO-induced CRS from the patient perspective, where to date this has been mainly clinically assessed using diverse assessments.
Authors
- Paúl Cordero (ORCID: https://orcid.org/0000-0001-9236-2268)
- Matthew Reaney (ORCID: https://orcid.org/0000-0003-2918-722X)
- James Turnbull
- Catherine Coulouvrat
- Laurence Lucats (ORCID: https://orcid.org/0000-0002-4735-0951)
- Joyce R. Talavera
- Benoît Arnould (ORCID: https://orcid.org/0000-0003-3160-5347)
- Giovanni Abbadessa (ORCID: https://orcid.org/0009-0007-2823-1870)
- Elizabeth Wells
- Sophie R. Van Tomme
Institutions
- IQVIA (United Kingdom) (GB)
- Sanofi (France) (FR)
- AVEO Oncology (United States) (US)
- Health Services Research & Development (US)
- IQVIA (United States) (US)
- IQ Solutions (US)
- National Patient Safety Foundation (US)
Publication Details
- Journal
- Oncology and Therapy
- Published
- 2025-10-03
- DOI
- https://doi.org/10.1007/s40487-025-00383-x
- Primary Topic
- CAR-T cell therapy research
- Type
- article
- Field-Weighted Citation Impact
- 0.00